Orilanolimab (Anti-FcRn (FCGRT & B2M))

Ask supplier a question | View on supplier's website

Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Supplier	Selleck Chemicals
Product #	A3000
Sku #	A3000-1mg*25
Pricing	1mg*25, $5070.00

Feedback